CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target

द्वारा Friman, Tomas, Chernobrovkin, Alexey, Martinez Molina, Daniel, Arnold, Laurence
में प्रकाशित SLAS Discov (2021)

Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1

द्वारा Shaw, Joseph, Dale, Ian, Hemsley, Paul, Leach, Lindsey, Dekki, Nancy, Orme, Jonathan P., Talbot, Verity, Narvaez, Ana J., Bista, Michal, Martinez Molina, Daniel, Dabrowski, Michael, Main, Martin J., Gianni, Davide
में प्रकाशित SLAS Discov (2018)

Cellular Active N-Hydroxyurea FEN1 Inhibitors Block Substrate Entry to the Active Site

द्वारा Exell, Jack C., Thompson, Mark J., Finger, L. David, Shaw, Steven J., Debreczeni, Judit, Ward, Thomas A., McWhirter, Claire, Siöberg, Catrine L. B., Martinez Molina, Daniel, Mark Abbott, W., Jones, Clifford D., Nissink, J. Willem M., Durant, Stephen T., Grasby, Jane A.
में प्रकाशित Nat Chem Biol (2016)